Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

James Garner Insider Profile

4 Followers

James Garner, Chief Executive Officer at Percheron Therapeutics, holds 74.90M shares in Percheron Therapeutics (Ticker: PERCF), holds 781.82K shares in Kazia Therapeutics Ltd (Ticker: DE:NV9). Most recently, James Garner Bought ― shares of Percheron Therapeutics on Apr 15, 2026 for an estimated value of $107.00K.

James Garner's Trading History

PERCFPercheron Therapeutics		Apr 15, 2026Chief Executive OfficerInformative Buy107.00K$749.00K
NV9Kazia Therapeutics Ltd		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

James Garner insider profile FAQ

What stocks does James Garner hold?
James Garner holds: PERCF, DE:NV9 stocks.
What was James Garner’s latest transaction?
James Garner’s latest transaction was an Informative Buy of $107.00K.
What was James Garner's most profitable transaction?
James Garner’s most profitable transaction was an Informative Buy of PERCF stock on November 20, 2023. The return on the trade was -16.00%.
What is James Garner's role in Percheron Therapeutics?
James Garner's role in Percheron Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.